Incorrect Table: In the Original Contribution
entitled "Efaluzimab for Patients With Moderate to Severe Plaque Psoriasis:
A Randomized Controlled Trial" published in the December 17, 2003, issue of
THE JOURNAL (2003;290:3073-3080), Table 3 contained erroneous numbers for mean (SD) and median (IQR) placebo
group improvement; additionally, erroneous PASI improvement percentage headings
were shown. The correct table is shown below.
Efalizumab for Patients With Moderate to Severe Plaque Psoriasis: A Randomized Controlled Trial. JAMA. 2004;291(9):1070. doi:10.1001/jama.291.9.1070